Delivery Order SPE2DX22D0099-SPE2D826FAD7D
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,257.39 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order is being performed at the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,637.83 to AmerisourceBergen Drug Corp on December 6, 2025, with completion expected by December 8, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract is non-set-aside and competitively awarded,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $94,752.62 to AmerisourceBergen Drug Corp on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was made on a competitive basis without set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,717.64 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $903,311.36 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The delivery order is being performed...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was made on a non-set-aside, competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,343.79 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $46,304.70 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order will be performed at the awardee's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $54,484.55 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, competitively awarded delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $47,539.81 to AmerisourceBergen Drug Corp on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price, non-set-aside delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAD7DDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $44,121.84 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and involves the delivery of pharmaceutical products and medical supplies to support federal healthcare needs, with performance occurring at the company's Corporate Office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for military and veteran healthcare systems through its federal contract portfolio. The company's pharmaceutical supply capabilities encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime vendor under DLA's comprehensive global pharmaceutical support program, AmerisourceBergen fulfills delivery orders for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating extensive experience in meeting federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.1k | 12/7/25 |